Evidence Hub

Primary Aldosteronism: Seismic Shifts

John W. Funder

The Journal of Clinical Endocrinology & Metabolism, 2015

14 citations

Abstract

Jerome Conn, the father of primary aldosteronism (PA), proposed that the syndrome may account for approximately 20% of patients with blood pressure (BP) elevation. For decades thereafter, conventional wisdom considered PA a rare (<1%) and relatively benign form of hypertension, which we now know is not the case. The first seismic shift came with the introduction of screening for PA by the aldosterone-to-renin ratio (ARR); on this basis, followed by confirmatory/exclusion testing, it is now recognized that PA represents 5–10% of hypertension. Over the past 5 years, there have been two more major advances. The first is the demonstration that a variety of somatic—ie, confined to the adrenal cortex—mutations have been found in what are now most aldosterone-producing adenomas. The first, and most common, mutation was that in KCNJ5, a component of the Kir3.4 potassium channel; subsequently, mutations in Na+ and Ca++ ATPases, Ca++ channels, and β-catenin have been described. The initial findings have been confirmed and replicated worldwide (1), ongoing exploration is intense, and the diagnostic and therapeutic aspects are yet to be determined.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free